Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-01

Clinical Trial Update: Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the combination of dronabinol and clonidine for cannabis dependence in patients with schizophrenia was terminated; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)
  • Dronabinol (dronabinol)

Snippet

Sponsor: Mclean Hospital | Conditions: Cannabis Dependence, Marijuana Dependence | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-08-01